New progress in angiogenesis therapy of cardiovascular disease by ultrasound targeted microbubble destruction

41Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Angiogenesis plays a vital part in the pathogenesis and treatment of cardiovascular disease and has become one of the hotspots that are being discussed in the past decades. At present, the promising angiogenesis therapies are gene therapy and stem cell therapy. Besides, a series of studies have shown that the ultrasound targeted microbubble destruction (UTMD) was a novel gene delivery system, due to its advantages of noninvasiveness, low immunogenicity and toxicity, repeatability and temporal and spatial target specificity; UTMD has also been used for angiogenesis therapy of cardiovascular disease. In this review, we mainly discuss the combination of UTMD and gene therapy or stem cell therapy which is applied in angiogenesis therapy in recent researches, and outline the future challenges and good prospects of these approaches. © 2014 Yang-Ying Liao et al.

Cite

CITATION STYLE

APA

Liao, Y. Y., Chen, Z. Y., Wang, Y. X., Lin, Y., Yang, F., & Zhou, Q. L. (2014). New progress in angiogenesis therapy of cardiovascular disease by ultrasound targeted microbubble destruction. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/872984

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free